video thumbnail

Adverse Cutaneous Drug Eruptions (Dr. Thomas King)

Duration: 34:43

Write A New Comment

2 Comments

...

mhundley@*.com

Jan 06 2024, 12:57 am

Thank you, Dr King. Excellent presentation!

...

susan4@*.com

Jan 05 2024, 11:43 pm

Very clear and succinct. Thank you.

This talk covers the presentation, diagnosis, and management of adverse cutaneous drug eruptions. It highlights the red flags and further details about severe adverse cutaneous drug eruptions including Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS syndrome (drug reaction with eosinophilia and systemic symptoms), and AGEP (acute generalized exanthematous pustulosis) and how to manage these.

  1. Recognize diverse cutaneous manifestations linked to drug exposure.
  2. Develop strategies for managing mild cutaneous drug eruptions effectively.
  3. Differentiate severe reactions like TEN, SJS, DRESS, and AGEP for accurate diagnosis.
  4. Understand the significance of erythroderma in adverse drug reactions.
  5. Utilize diagnostic tools, including clinical evaluation and lab tests, for precision.
  6. Implement collaborative, multidisciplinary care for comprehensive patient management.

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

  • Dr. Thomas King

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Dr. Thomas King UCB pharma - conference fees (2020 and 2021) Sanofi - promotional talks (2021) Abbvie - creation of educational resources, promotional talks, digital advisory groups (2020 and 2021).

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Dermatology

Related Videos